Close
Listen

Aims

Our group works on the genomics and genetics of many rare diseases a.k.a. Mendelian disorders by standard next generation sequencing (NGS) approaches we pioneered such as exome sequencing and genome sequencing.

Recent efforts include applications of innovative long-read approaches, that allow a more complete assessment of a patient’s genome, including long-read sequencing and optical genome mapping.

A particular focus in our group is the identification of the genetic basis of immune diseases, with the most recent identification of a novel immunodeficiency that predisposes men to severe COVID-19, and a missing SCID gene.

We have been strongly involved in the EU-funded H2020 project SOLVE-RD and have received a NWO/ZonMW VICI grant “SOLVE-IEI - Solving Enigmas of Undiagnosed Inborn Errors of Immunity”.

With this support and together with our network we pioneer novel and disruptive technologies that allow new scientific insights and rapid translation into clinical and diagnostic practice.


go to main content
Research Research groups Genomic technologies for immune-mediated and infectious diseases

About Genomic technologies for immune-mediated and infectious diseases

We focus on the application of the latest genomic technologies to understand human disease. A particular emphasis is put on the understanding of genetic defects that explain rare disease specifically immune diseases, such as inborn errors of immunity (IEIs).

Research group leader

prof. dr. Alexander Hoischen

Aims

See our most important goals.

read more

Publications

See some of our most important scientific articles.

read more
Close
Listen

Publications

See the publication list of the research group leader on Web of Science.


Profile page

See the group leader's profile.

see page

Research programs

Programs that are connected to this research group.